Open AccessVitamin D3 Supplementation: An Option Associated with The Treatment of Multiple Sclerosis:
Author(s) -
Eliza Miranda Ramos,
Matheus Dullius de Lima,
Jéssica Eloy Cunha Gonzalez,
Gilberto Gonçalves Facco,
Francisco José Mendes dos Reis,
Elaine Silva de Pádua Melo,
Valter Aragão do Nascimento
Publication year - 2020
Language(s) - English
Resource type - Journals
ISSN - 2411-2933
DOI - 10.31686/ijier.vol8.iss5.2363
Subject(s) - multiple sclerosis , observational study , medicine , randomized controlled trial , meta analysis , vitamin d and neurology , vitamin , disease , physical therapy , immunology
Multiple sclerosis (MS) is a chronic complex neurodegenerative disease. A systematic review and meta-analysis were conducted on observational studies and analytics on impact of Vitamin D supplementation in patients with Multiple Sclerosis. In our research, a total of 457 articles were selected and identified for analysis. This systematic review article and meta-analysis, which included evidence from randomized controlled trials conducted with patients with multiple sclerosis, revealed that Vitamin D3 supplementation is effective as an option associated with the treatment of this disease, and that it also has a diffuse protective role against various remission outbreaks in the health. Doses (50,000 IU/week) are appropriate to restore neuroimmunological parameters when used within 12 weeks.